MDV-1 LIVING VACCINE

Country: Awstralja

Lingwa: Ingliż

Sors: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredjent attiv:

MAREK'S DISEASE

Disponibbli minn:

INTERVET AUSTRALIA PTY LIMITED

INN (Isem Internazzjonali):

MDV (BH 16)

Għamla farmaċewtika:

MISC. VACCINES OR ANTI SERA

Kompożizzjoni:

MAREK'S DISEASE VACCINE-GENERAL Active 0.0 U

Unitajiet fil-pakkett:

!1mL Amp; !500 Doses; *1.8mL Amp; *1000Doses; 200mL; Diluent

Klassi:

VM - Veterinary Medicine

Manifatturat minn:

INTERVET AUSTRALIA

Grupp terapewtiku:

POULTRY CHICKS | CHICKENS | DAY OLD CHICKS | HATCHLINGS

Żona terapewtika:

IMMUNOTHERAPY

Indikazzjonijiet terapewtiċi:

MAREK'S DISEASE | HERPES VIRUS OF TURKEYS (HVT)

Sommarju tal-prodott:

Poison schedule: 0; Withholding period: WHP: Nil.; Host/pest details: POULTRY CHICKS: [MAREK'S DISEASE]; Poison schedule: 0; Withholding period: ; Host/pest details: POULTRY CHICKS: [MAREK'S DISEASE]; For the active immunisation of chickens at 1 day old against Marek's Disease when used in association with but not mixed with Intervet's HVT-CA vaccine.

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2023-07-01

Fuljett ta 'informazzjoni

Intervel Australia Pty Llmtted-
Label
For
MDV
~
1 Living Vaccine
AB.N.
79 008 467 034
Vaccine
Ampoule
Label
V5>V6
Version 6
}:>
Appropriate doses
incorporated
for
ampoule
size.
)-
Either 1 mL (500 dose) OR 1.8 mL (1000 dose) to be deleted as
appropriate for
batch.
'FORAMliAiiREAiMEifr
ONLY
MDV.1
LiYlng
Yal:e!ne
1/111.(500
d_ll
U
IJ'i
(1000
dole)
READ
THE
ENa.oaEO
LEAFLET
BEfORE
USING
TIIS
PRODUCT
S"'-In~idnilrogOl'l
[IlJ
Exp:
lnIer¥oIAuohkP.t. Ph:
(GJ)
5442$(111
Milk
52319/
0'00;(
_231712002_
Signatur
MDV~1
Label suite
,
.
Page I
of3
Intervet
Austro.lio.
Pty Ltd
MDV-l
Living
Vaccine
-
Product
Leo.flet
Version
8
READ SAFETY DIRECTIONS BEFORE
OPENING OR USING
FOR
ANIMAL
TREATMENT ONLY
MDV·1
Living
Vaccine
Active constituent: Marek's diseasevirus,
living,
cell-
associated, strain BH 16.
Minimum
titre at end of
shelf life:
106.09
TCID
so
per
mL
For the active immunisatlon of chickens at 1 day-old
against Marek's
Disease
when used in association
with but not mixed with Intervet's
HVT-CA
Vaccine.
1
mL
(500
dose)/1.8 mL
(1000
dose) per ampoule
(delete
as
appropriate)
DIRECTIONS FOR USE
Restraints:
•
Give subcutaneously only.
Precautions:
•
MDV-1
living
Vaccine Is not recommended
for mixing
with
Intervet's
HVT-CA VaccIne
in
a single Injection.
•
Vaccinate only healthy birds.
•
Avoid placing chickens In contaminated
facilities.
•
Avoid stress conditions during and following
vaccination.
•
Ensure exposure to disease Is minimised as
much
as
possible
Dosage and
Administration:
•
USE ALL PRODUCTWITHIN
1
HOUR
OF
OPENING
&
MIXING
•
Administer a full dose to each bird.
•
Vaccinate all birds on the farm at one time.
•
The vaccine is recommended tor use in
one-day-old chicks.
•
Sterilise all injection apparatusby
boiting
(or
equivalent)before use. Avoid use of
strong
disinfectants on apparatus usedfor live
vaccines.
•
A single dose of the
vaccine
is administered
subcutaneously. Two 500 dose ampoulesor one
1000 dose ampouleof vaccine and one 200 mL
pack of
IntervetMareks Disease
Vaccines
Diluent
are requir

Karatteristiċi tal-prodott

PRODUCT NAME: MDV-1 LIVING VACCINE
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 6
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Cells SPF chicken embryo, containing Marek’s Disease Virus, serotype
1 (living,
attenuated) freeze dried. Supplied with an aqueous solution of
stabilisers and buffering
agents.
TRADE NAME:
MDV-1 LIVING VACCINE
PRODUCT CODE:
3958
RECOMMENDED USE:
For the active immunisation of chickens at 1 day old against Marek's
Disease when used
in association with but not mixed with Intervet's HVT-CA vaccine.
APVMA NO:
52379
CREATION DATE:
February, 2007
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S23, S37, S24/25. Do not breathe mists. Wear suitable gloves. Avoid
contact with skin and eyes.
SUSDP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Two component system; attenuated virus is a pellet or powder while
diluent is a
clear, colourless liquid.
ODOUR:
Mild odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. However
product may be mildly
irritating, although unlikely to cause anything more than mild
transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. However product may be mildly irri